Printer Friendly
The Free Library
19,595,260 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Clinical Data to Present at the 2008 BMO Capital Markets Focus on Healthcare Conference in New York.


NEWTON, Mass. -- Clinical Data, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CLDA CLDA California Lyme Disease Association ), a leader in the development of targeted therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
 and predictive tests from its growing portfolio of proprietary genetic biomarkers, announced today that Drew Fromkin, President and Chief Executive Officer will present at the 2008 BMO BMO Bank of Montreal (Canada)
BMO Before Market Open
BMO Biometrics Management Office
BMO Ballistic Missile Office
BMO British Mathematical Olympiad
BMO Balkan Mathematical Olympiad
BMO Business Management Office
 Capital Markets Focus on Healthcare Conference at the Millennium Broadway Hotel on Tuesday, August 5th at 8:30am Eastern Time.

Interested parties can access a live audio web cast of the presentation at www.clda.com. A replay of the presentation will be available at the same location.

About Clinical Data, Inc.

Clinical Data, Inc. is unlocking the potential of molecular discovery from Targeted Science to Better Healthcare[TM]. Its PGxHealth([R]) division focuses on proprietary biomarker biomarker /bio·mark·er/ (bi´o-mahr?ker)
1. a biological molecule used as a marker for a substance or process of interest.

2. tumor marker.


bi·o·mark·er
n.
1.
 and pharmacogenetic test development as well as targeted therapeutics to help predict drug safety and efficacy, thereby reducing health care costs and improving clinical outcomes. Its Cogenics([R]) division provides genomics services to both research and regulated environments. Through these divisions, Clinical Data is leveraging advances in molecular discovery to provide tangible benefits for patients, doctors, scientists and health plans worldwide. Visit the Company's website at www.clda.com for more information.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Conference news
Date:Aug 1, 2008
Words:191
Previous Article:Porsche Reports July Sales.
Next Article:Bristol-Myers Squibb Announces Completion of ConvaTec Divestiture.
Topics:



Related Articles
Clinical Data to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference.
Medtronic to Participate in the BMO Capital Markets Health Care Conference.
Possis Medical, Inc., to Present at the BMO Capital Markets Focus on Healthcare Investor Conference.
Clinical Data, Inc. to Present at Visiongain's Biomarkers Conference 2008.
YAI/National Institute for People with Disabilities Network 29th Annual International Conference.
Antares Pharma to Present at the BMO Capital Markets Healthcare Conference.
ArQule, Inc. to Present at BMO Capital Markets Focus on Healthcare Conference.
Bio-Imaging Technologies to Present at the BMO Capital Markets 8th Annual Focus on Healthcare Conference August 6, 2008 in New York.
Clinical Data Acquires Adenosine Therapeutics.
St. Jude Medical To Present at Morgan Stanley Global Healthcare Unplugged Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles